Skip to content

Ventilatory Functions, Oxygen Saturation, and Quality of Life Response to Long Time Cement Dust Exposure

Ventilatory Functions, Oxygen Saturation, and Quality of Life Response to Long Time Cement Dust Exposure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05047497
Enrollment
49
Registered
2021-09-17
Start date
2018-05-01
Completion date
2019-05-29
Last updated
2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Diseases

Brief summary

Thousands of people are working daily in a dusty environment. Many studied reported respiratory symptoms and ventilatory disorders among Factory workers who exposed to cement dust. But the evidence for respiratory effect and daily activities over a long time of cement dust exposure has not been conclusive

Detailed description

A total of 49 subjects working in a cement production factory were assessed and divided into three groups according to the total period of work exposure. Groupe A (18 subjects) with work period \< 10 years, group B (13 subjects) with work period 10-15 years, group C (18 subjects) with work period \> 15 years. The ventilatory functions, oxygen saturation, and quality of life were assessed in the three groups. RESULTS: The study results revealed a statistically significant difference between the three groups in the mean values of FVC (%), FEV1/FVC (%), SPO2.

Interventions

DIAGNOSTIC_TESTquestionaire and ventilatory function test

we assessed the arterial blood gases and the ventilatory functions and quality of life of whole three groups

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
25 Years to 50 Years

Inclusion criteria

* The ages were between 25 to 50 years old. * the body mass index ranged from (18,5 - 29,9) kg/m2.

Exclusion criteria

* Age less than 25 or more 50. * Any chronic diseases * severe musculoskeletal and cardiopulmonary disorders and * Class III Obesity (35-39.9 kg/m 2) or more

Design outcomes

Primary

MeasureTime frameDescription
The ventilatory functions8 monthsventilatory function tests were used to assess FVC (%), FEV1/FVC (%),PEF (%), FEV1 (%)
oxygen saturation8 monthsmeasuring oxygen saturation using SPo2
quality of life were assessed8 monthsthe mean values of the physical functioning item and energy/fatigue item in the quality of life questionnaire

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026